Pharmaceutical compositions and use thereof

Details for Australian Patent Application No. 2006259261 (hide)

Owner Myriad Genetics, Inc.

Inventors Zentner, Gaylen M.; McRea, James C.; Shih, Chung

Agent Peter Maxwell & Associates

Pub. Number AU-A-2006259261

PCT Pub. Number WO2006/138608

Priority 60/691,362 16.06.05 US

Filing date 16 June 2006

Wipo publication date 28 December 2006

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/00 (2006.01)

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 36/00 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/138608 Priority application(s): WO2006/138608

22 December 2011 Assignment before Grant

  Myriad Genetics, Inc. The application has been assigned to Myrexis, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259262-Treatment of inflammatory conditions

2006259259-Cell signaling genes and related methods